The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: Three years after testing

Genetics in Medicine

Volumn 9, Issue 5, 2007, Pages 290-297

  Collins, Veronica R ^a,i   Meiser, Bettina ^b,c   Ukoumunne, Obioha C ^a,d   Gaff, Clara ^e,f,g   St John, D James ^g,h   Halliday, Jane L ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Genetic Health Services Victoria   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g ROYAL MELBOURNE HOSPITAL   (United States)

^h National Cancer Control Initiative   (Australia)

ⁱ ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Colonoscopy; Endometrial cancer; Genetic testing; Hereditary nonpolyposis colorectal cancer; Psychological impact

Indexed keywords

ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC PROCEDURES; GYNECOLOGICAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; SCORING SYSTEM; SEX RATIO; STATISTICAL SIGNIFICANCE;

ADULT; ANXIETY; AUSTRALIA; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH BEHAVIOR; HUMANS; MALE; MUTATION; QUESTIONNAIRES;

EID: 34249026408     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e31804b45db     Document Type: Article

References (40)

1. Katballe N, Christensen M, Wikman FP, Orntoft TF, et al. Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut 2002;50:43-51.
2. de la Chapelle A. The incidence of Lynch syndrome. Fam Cancer 2005;4:233-237.
3. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999;36:801-818.
4. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-110.
5. Aarnio M, Sankila R, Pukkala E, Salovaara R, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-218.
6. Van de Water NS, Jeevaratnam P, Browett PJ, Stewart SM, et al. Direct mutational analysis in a family with hereditary non-polyposis colorectal cancer. Aust NZ J Med 1994;24:682-686.
7. Liu B, Parsons RE, Hamilton SR, Petersen GM, et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 1994;54:4590-4594.
8. Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, et al. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 2006;4:489-498.
9. Hampel H, Stephens JA, Pukkala E, Sankila R, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005;129:415-421.
10. Carayol J, Khlat M, Maccario J, Bonaiti-Pellie C. Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. J Med Genet 2002;39:335-339.
11. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-834.
12. de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006;130:665-671.
13. Breheny N, Geelhoed E, Goldblatt J, Ee H, et al. Economic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma. Commun Genet 2006;9:98-106.
14. Meiser B, Collins V, Warren R, Gaff C, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC). Clin Genet 2004;66:502-511.
15. Collins V, Meiser B, Gaff C, St. John DJ, et al. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 2005;104:273-281.
16. Australian Cancer Network. Guidelines on familial aspects of cancer. Sydney: Australian Cancer Network, 1999.
17. Human Genetics Society of Australasia. Guidelines for DNA presymptomatic and predictive testing for genetic disorders. Sydney: Human Genetics Society of Australasia, 2002.
18. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the prevention, early detection and management of colorectal cancer. Sydney: The Cancer Council Australia and Australian Cancer Network, 2005.
19. Myers RE, Ross E, Jepson C, Wolf T, et al. Modeling adherence to colorectal cancer screening. Prev Med 1994;23:142-151.
20. Moorey S, Greer S, Watson M, Gorman C, et al. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991;158:255-259.
21. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
22. Marteau T, Bekker H. The development of a six-item short-form of the state scale of the state-trait anxiety inventory (STAI). Br J Clin Psychol 1992;31:301-306.
23. Michie S, French DP, Marteau TM. Predictive genetic testing: mediators and moderators of anxiety. Int J Behav Med 2002;9:309-321.
24. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979;41:209-218.
25. Thewes B, Meiser B, Hickie IB. Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psychooncology 2001;10:459-468.
26. Goldstein H. Multilevel statistical models. London: Arnold, 1995.
27. Davison A, Hinkley D. Bootstrap methods and their application. Cambridge: Cambridge University Press, 1997.
28. Aktan-Collan K, Haukkala A, Mecklin J-P, Uutela A, et al. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 2001;93:608-611.
29. Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, et al. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year posttest. Genet Test 2005;9:54-65.
30. Gritz ER, Peterson SK, Vernon SW, Marani SK, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:1902-1910.
31. Halbert CH, Lynch H, Lynch J, Main D, et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 2004;164:1881-1887.
32. Hadley DW, Jenkins JF, Dimond E, de Carvalho M, et al. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2004;22:39-44.
33. Ponz de Leon M, Benatti P, Di Gregorio C, Pedroni M, et al. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 2004;90:882-887.
34. Michie S, Weinman J, Miller J, Collins V, et al. Predictive genetic testing: high risk expectations in the face of low risk information. J Behav Med 2002;25:33-50.
35. Michie S, Smith JA, Senior V, Marteau TM. Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet 2003;119A:340-347.
36. Bleiker EMA, Menko FH, Taal BG, Kluijt I, et al. Experience of discharge from colonoscopy of mutation negative HNPCC family members. J Med Genet 2003;40:e55.
37. Stanley AJ, Gaff CL, Aittomaki AK, Fabre L, et al. Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC). Med J Aust 2000;172:313-316.
38. Australian Government Department of Health and Ageing. National Bowel Cancer Screening Program. Available at http://www.cancerscreening.gov.au/ internet/screening/publishing.nsf/Content/bowel-about. Accessed January 17, 2007.
39. Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, et al. Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med 2003;25:187-194.
40. Schmeler KM, Lynch HT, Chen LM, Munsell MF, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006;354:261-269.